MSD Partners’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-146,675
Closed -$140K 22
2023
Q4
$140K Hold
146,675
0.01% 21
2023
Q3
$158K Hold
146,675
0.01% 47
2023
Q2
$132K Sell
146,675
-706
-0.5% -$626 0.01% 49
2023
Q1
$125K Hold
147,381
0.01% 50
2022
Q4
$137K Hold
147,381
0.01% 53
2022
Q3
$251K Hold
147,381
0.02% 58
2022
Q2
$315K Hold
147,381
0.02% 65
2022
Q1
$523K Sell
147,381
-294,762
-67% -$855K 0.03% 63
2021
Q4
$1.64M Buy
442,143
+294,762
+200% +$1.81M 0.02% 80
2021
Q3
$1.09M Buy
+147,381
New +$1.26M 0.03% 67

Other funds holding CLOV

MSD Partners's CLOV Position: Q1 2024 in Review

MSD Partners sold out of Clover Health Investments (CLOV) in Q1 2024, closing a stake of 146,675 shares — an estimated $140K sold.

MSD Partners first reported a position in CLOV in Q3 2021 and held it in 10 quarters. The position peaked at $1.64M in Q4 2021. 137 funds tracked by Wall St. Rank hold CLOV as of Q1 2024.

  • MSD Partners reported no remaining Clover Health Investments position as of Q1 2024 after selling out during the quarter.
  • MSD Partners sold 146,675 Clover Health Investments shares in Q1 2024, an estimated $140K.
  • MSD Partners first reported a position in Clover Health Investments in Q3 2021 and held it in 10 quarters.
  • MSD Partners's Clover Health Investments position peaked at $1.64M in Q4 2021.
  • 137 funds tracked by Wall St. Rank held Clover Health Investments as of Q1 2024.

Based on MSD Partners's 13F filing for Q1 2024, filed 15 May 2024.